1,281 top medical experts on Myelodysplastic Syndromes across 41 countries and 33 U.S. states, including 1,256 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into acute myeloid leukemia.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Bone Marrow Diseases (741) and Narrower Categories: GATA2 Deficiency (152), Paroxysmal Hemoglobinuria (615), Refractory Anemia (329), Sideroblastic Anemia (581).
  4. Clinical Trials ClinicalTrials.gov : at least 1,637 including 153 Active, 781 Completed, 281 Recruiting
  5. Synonyms: Dysmyelopoietic Syndromes


  

        

                    


    Computing Expert Listing ...

);